Marcus Conlé
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marcus Conlé has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Margot Schüller
GIGA Institute of Asian Studies
2 shared publicationsMarkus Taube
Department: Mercator School of Management, University of Duisburg‐Essen, Duisburg, Germany
2 shared publications- Tobias Ten Brink
Constructor University Bremen Germany
2 shared publications - Cornelia Storz
Goethe University
1 shared publication - David Shim
University of Groningen
1 shared publication - Henning Kroll
Fraunhofer ISI, Karlsruhe, Germany
1 shared publication
Latest Publications
- Open Access
- 11 October 2022
- Published by Taylor & Francis in Industry and Innovation
- Vol. 30 (6) , 694-718
Innovation platforms as a tool for anchoring non-local knowledge: smart specialisation strategies in Guangdong, China
Innovation platforms can be useful for promoting the diversification of regional industrial paths. Until recently, the literature had depicted such platforms primarily as a tool for enabling local knowledge recombination – and not for anchoring non-local knowledge. In many regions, however, ‘smart specialisation strategies’ for modernising and transforming industrial structures are difficult to implement without transplantation of non-local knowledge. This paper explores innovation platforms as a tool for anchoring non-local knowledge. We elaborate on recent Chinese experiences by studying diversification-oriented regional innovation policy in Guangdong province. We employ an embedded single-case study design, involving a regionally typical diversification strategy, which we substantiate by tracing platform development with two non-local actors, a university and a technology firm. The paper reveals that non-local actors can play an important role in unlocking regional industrial development potential, especially if platforms enable these actors to relate to local industry by performing desired intermediary functions.
- 11 October 2022
- Published by Taylor & Francis in Industry and Innovation
- Vol. 30 (6) , 694-718
Open AccessInnovation platforms as a tool for anchoring non-local knowledge: smart specialisation strategies in Guangdong, China
Innovation platforms can be useful for promoting the diversification of regional industrial paths. Until recently, the literature had depicted such platforms primarily as a tool for enabling local knowledge recombination – and not for anchoring non-local knowledge. In many regions, however, ‘smart specialisation strategies’ for modernising and transforming industrial structures are difficult to implement without transplantation of non-local knowledge. This paper explores innovation platforms as a tool for anchoring non-local knowledge. We elaborate on recent Chinese experiences by studying diversification-oriented regional innovation policy in Guangdong province. We employ an embedded single-case study design, involving a regionally typical diversification strategy, which we substantiate by tracing platform development with two non-local actors, a university and a technology firm. The paper reveals that non-local actors can play an important role in unlocking regional industrial development potential, especially if platforms enable these actors to relate to local industry by performing desired intermediary functions.
- Open Access
- 5 December 2021
- Published by Springer Nature in The Journal of Technology Transfer
- Vol. 48 (1) , 147-180
University satellite institutes as exogenous facilitators of technology transfer ecosystem development
Universities can contribute to knowledge-based regional development not only in their home region but also in other regions. In a number of countries, universities have established university satellite institutes in additional (host) regions to promote research and technology transfer there. We investigate the role of university satellite institutes in the industrial development of regions, which, albeit not economically marginal, suffer from a weak knowledge infrastructure, limited absorptive capacities for external knowledge in the business sector and hence a low degree of attractiveness for non-local knowledge actors. Despite policy recommendations in favor of establishing satellite institutes, there has only been limited empirical research on this phenomenon, particularly concerning technology transfer ecosystem development. To fill this gap, we provide an exploratory case study of university satellite institutes in the Pearl River Delta of China’s Guangdong province. We show how such institutes can be successful in facilitating the development of their host region’s technology transfer ecosystems and demonstrate why they should be conceptually included in our existing understanding of third mission activities. Our research centers on the interplay of geographical proximity and non-spatial, organized proximity in the development of interregional knowledge bridges and entrepreneurial opportunities. We argue that the university’s geographical proximity is only successful if the satellite institute, by facilitating organized proximity, promotes the geographical proximity of further knowledge actors, hereby propelling ecosystem development.
- 5 December 2021
- Published by Springer Nature in The Journal of Technology Transfer
- Vol. 48 (1) , 147-180
Open AccessUniversity satellite institutes as exogenous facilitators of technology transfer ecosystem development
Universities can contribute to knowledge-based regional development not only in their home region but also in other regions. In a number of countries, universities have established university satellite institutes in additional (host) regions to promote research and technology transfer there. We investigate the role of university satellite institutes in the industrial development of regions, which, albeit not economically marginal, suffer from a weak knowledge infrastructure, limited absorptive capacities for external knowledge in the business sector and hence a low degree of attractiveness for non-local knowledge actors. Despite policy recommendations in favor of establishing satellite institutes, there has only been limited empirical research on this phenomenon, particularly concerning technology transfer ecosystem development. To fill this gap, we provide an exploratory case study of university satellite institutes in the Pearl River Delta of China’s Guangdong province. We show how such institutes can be successful in facilitating the development of their host region’s technology transfer ecosystems and demonstrate why they should be conceptually included in our existing understanding of third mission activities. Our research centers on the interplay of geographical proximity and non-spatial, organized proximity in the development of interregional knowledge bridges and entrepreneurial opportunities. We argue that the university’s geographical proximity is only successful if the satellite institute, by facilitating organized proximity, promotes the geographical proximity of further knowledge actors, hereby propelling ecosystem development.
- 6 November 2019
- Published by Taylor & Francis
- p. 126-148
Architecture-based innovation strategies in the development of China’s passenger vehicle sector
Architecture-based innovation strategies have the potential to disrupt sectoral orders if the related product designs are successful in the market while incumbent market leaders are unable to change the relevant organizational patterns to accommodate similar product designs. The automotive industry is specifically associated with the development of the internal combustion engine (ICE) and the model case for an industry featuring integral product designs. After the automobile sector had settled on an ICE–based dominant design, a number of connected shifts in product and process technologies have gradually transformed the sector; first, from one featuring an open-modular to a closed-modular and to a closed-integral product architecture. The chapter explores innovation in China can be explained in terms of an interplay of fragmented domestic industry architectures and a general trend in many industries toward the modularization of product architectures. The secondary segments of the passenger vehicle sector have entered the spotlight particularly after the country’s accession to the World Trade Organization in 2001.
- 6 November 2019
- Published by Taylor & Francis
- p. 126-148
Architecture-based innovation strategies in the development of China’s passenger vehicle sector
Architecture-based innovation strategies have the potential to disrupt sectoral orders if the related product designs are successful in the market while incumbent market leaders are unable to change the relevant organizational patterns to accommodate similar product designs. The automotive industry is specifically associated with the development of the internal combustion engine (ICE) and the model case for an industry featuring integral product designs. After the automobile sector had settled on an ICE–based dominant design, a number of connected shifts in product and process technologies have gradually transformed the sector; first, from one featuring an open-modular to a closed-modular and to a closed-integral product architecture. The chapter explores innovation in China can be explained in terms of an interplay of fragmented domestic industry architectures and a general trend in many industries toward the modularization of product architectures. The secondary segments of the passenger vehicle sector have entered the spotlight particularly after the country’s accession to the World Trade Organization in 2001.
- 2 October 2019
- Published by Emerald Publishing in Journal of Science and Technology Policy Management
- Vol. 10 (3) , 686-707
Recent developments in China’s biopharmaceutical industry (2012-2017)
Purpose: The paper aims to take stock of China’s recent biopharmaceutical industry development by analyzing product innovation and changes in the firms’ product portfolios during the five-year period between 2012 and 2017. Design/methodology/approach: The paper introduces a classification of biopharmaceutical products. By applying the classification to the product data of China’s drug regulator, the CFDA, it becomes possible to trace the developments within the sector by looking at changes in the number of firms within each subgroup and changes in the number of subgroups in which each firm is involved. The classification allows an evaluation of the latest product innovation achievements. Findings: The paper demonstrates a mild shakeout of firms in the relatively long-existing domestic market segments, a trend toward more specialized product portfolios and an enduring prevalence of innovation strategies aimed at exploiting relatively unpopulated domestic market niches instead of pioneering entirely new products. Especially the capability of upgrading to second-generation protein therapeutics has become a key criterion for separating the wheat and the chaff in China’s domestic sector. The paper moreover points out the relevance of acquisitions as a corporate growth strategy. Research limitations/implications: The research does not consider complementary indicators, product pipelines in particular. Future research should compare patterns across emerging economies. Originality/value: The paper is unique in using the CFDA database for systematic academic research on (bio)pharmaceutical innovation and in introducing a biopharmaceutical product classification to trace innovative activities and changes in corporate product portfolios over time.
- 2 October 2019
- Published by Emerald Publishing in Journal of Science and Technology Policy Management
- Vol. 10 (3) , 686-707
Recent developments in China’s biopharmaceutical industry (2012-2017)
Purpose: The paper aims to take stock of China’s recent biopharmaceutical industry development by analyzing product innovation and changes in the firms’ product portfolios during the five-year period between 2012 and 2017. Design/methodology/approach: The paper introduces a classification of biopharmaceutical products. By applying the classification to the product data of China’s drug regulator, the CFDA, it becomes possible to trace the developments within the sector by looking at changes in the number of firms within each subgroup and changes in the number of subgroups in which each firm is involved. The classification allows an evaluation of the latest product innovation achievements. Findings: The paper demonstrates a mild shakeout of firms in the relatively long-existing domestic market segments, a trend toward more specialized product portfolios and an enduring prevalence of innovation strategies aimed at exploiting relatively unpopulated domestic market niches instead of pioneering entirely new products. Especially the capability of upgrading to second-generation protein therapeutics has become a key criterion for separating the wheat and the chaff in China’s domestic sector. The paper moreover points out the relevance of acquisitions as a corporate growth strategy. Research limitations/implications: The research does not consider complementary indicators, product pipelines in particular. Future research should compare patterns across emerging economies. Originality/value: The paper is unique in using the CFDA database for systematic academic research on (bio)pharmaceutical innovation and in introducing a biopharmaceutical product classification to trace innovative activities and changes in corporate product portfolios over time.
- 20 July 2012
- Published by Emerald Publishing in Journal of Science and Technology Policy in China
- Vol. 3 (2) , 124-144
Anatomy of cluster development in China: the case of Health Biotech Clusters
Purpose – The purpose of this paper is to analyze the dynamics of China's health biotech clusters from an interregional perspective. By treating clustering as the result of firms' localization choices, the paper examines whether and why different types of firms agglomerate in the various locations.Design/methodology/approach – The paper employs a demographic approach that is inspired by the 2006 work of Romanelli and Feldman on cluster development in the USA. It categorizes China's clusters based on differences in the degree of policy support and the nature of the science base. Then, it draws a sample of 75 of China's most visible firms and analyses them in terms of entrepreneurial origin, their location and, if applicable, the location of their subsidiaries. By matching types of firms with types of clusters, the paper highlights some characteristics of China's regional development.Findings – Studies on China's high‐tech agglomerations unanimously complain about a lack of “creative buzz” compared to the vibrant clusters of for example, the Bay Area in the USA. The analysis indicates that the lack of a creative culture is associated with the anatomy of cluster development. China's clusters grow to a significant extent by attracting enterprise subsidiaries to their sites. The authors argue that these particular cluster anatomies are founded on China's capital market. As the capital market is not prepared to provide pre‐revenue firms with sufficient funds, firms have to earn revenue quickly in order to ensure their viability. Therefore, they concentrate on building up manufacturing capacity and exploiting given technologies. The main point is that local governments as major providers of financial support are instrumental in this process. The establishment of manufacturing subsidiaries in various locations rests on the rationale of collecting funds. This leads to the conclusion that national capital markets either reinforce or inhibit clustering depending on how much it allows the mobility of financial capital. Local government funds do not travel far. This has an impact on the firms' localization decisions and their business strategies, which, in turn, affects the “culture” inside the clusters.Research limitations/implications – This argument is based on a limited number of interviews conducted by the authors or other researchers. In order to corroborate the link between the capital market and local development trajectories, more evidence needs to be collected via interview surveys and other means to extract financial information.Originality/value – Unlike other research on Chinese clusters, this paper offers an interregional perspective based on a demographic approach. The argument is original in linking regional cluster dynamics with the national institutional set‐up.
- 20 July 2012
- Published by Emerald Publishing in Journal of Science and Technology Policy in China
- Vol. 3 (2) , 124-144
Anatomy of cluster development in China: the case of Health Biotech Clusters
Purpose – The purpose of this paper is to analyze the dynamics of China's health biotech clusters from an interregional perspective. By treating clustering as the result of firms' localization choices, the paper examines whether and why different types of firms agglomerate in the various locations.Design/methodology/approach – The paper employs a demographic approach that is inspired by the 2006 work of Romanelli and Feldman on cluster development in the USA. It categorizes China's clusters based on differences in the degree of policy support and the nature of the science base. Then, it draws a sample of 75 of China's most visible firms and analyses them in terms of entrepreneurial origin, their location and, if applicable, the location of their subsidiaries. By matching types of firms with types of clusters, the paper highlights some characteristics of China's regional development.Findings – Studies on China's high‐tech agglomerations unanimously complain about a lack of “creative buzz” compared to the vibrant clusters of for example, the Bay Area in the USA. The analysis indicates that the lack of a creative culture is associated with the anatomy of cluster development. China's clusters grow to a significant extent by attracting enterprise subsidiaries to their sites. The authors argue that these particular cluster anatomies are founded on China's capital market. As the capital market is not prepared to provide pre‐revenue firms with sufficient funds, firms have to earn revenue quickly in order to ensure their viability. Therefore, they concentrate on building up manufacturing capacity and exploiting given technologies. The main point is that local governments as major providers of financial support are instrumental in this process. The establishment of manufacturing subsidiaries in various locations rests on the rationale of collecting funds. This leads to the conclusion that national capital markets either reinforce or inhibit clustering depending on how much it allows the mobility of financial capital. Local government funds do not travel far. This has an impact on the firms' localization decisions and their business strategies, which, in turn, affects the “culture” inside the clusters.Research limitations/implications – This argument is based on a limited number of interviews conducted by the authors or other researchers. In order to corroborate the link between the capital market and local development trajectories, more evidence needs to be collected via interview surveys and other means to extract financial information.Originality/value – Unlike other research on Chinese clusters, this paper offers an interregional perspective based on a demographic approach. The argument is original in linking regional cluster dynamics with the national institutional set‐up.
- 23 July 2011
- Published by Springer Nature
- p. 109-128
Korean Innovation Governance Under Lee Myung-Bak – A Critical Analysis of Governmental Actors’ New Division of Labour
- 23 July 2011
- Published by Springer Nature
- p. 109-128
Korean Innovation Governance Under Lee Myung-Bak – A Critical Analysis of Governmental Actors’ New Division of Labour
- 23 November 2010
- Published by Emerald Publishing in Chinese Management Studies
- Vol. 4 (4) , 339-359
Regional specialization in China's biopharmaceutical industry
Purpose – The purpose of this paper is to explore patterns as well as determinants of regional specialisation in China's biopharmaceutical industry. It identifies and characterizes different types of enterprises engaged in the biopharmaceutical sector in terms of their business organisation and regional set up. Design/methodology/approach – Based on data compilations not yet employed in academic analysis as well as personal interviews in China, structural determinants and driving forces of development are analysed against the background of the innovation systems literature. Findings – The geography of innovation in China's biopharmaceutical industry is determined by both, government policy and the strategic location decisions of entrepreneurs. While local-government support of firm clustering has contributed to a dispersion of industrial activity throughout China, the firms” networks are spanning clusters. Effectively, domestic firms are turning into multi-regional companies locating activities such as R&D and manufacturing at different clusters. Originality/value – The paper adds to the literature in so far as it throws light on an until now under-researched field of China's innovation system. It identifies the concept of multi-regionalism among domestic non-state enterprises as an important parameter for understanding success and regional distribution of the industry.
- 23 November 2010
- Published by Emerald Publishing in Chinese Management Studies
- Vol. 4 (4) , 339-359
Regional specialization in China's biopharmaceutical industry
Purpose – The purpose of this paper is to explore patterns as well as determinants of regional specialisation in China's biopharmaceutical industry. It identifies and characterizes different types of enterprises engaged in the biopharmaceutical sector in terms of their business organisation and regional set up. Design/methodology/approach – Based on data compilations not yet employed in academic analysis as well as personal interviews in China, structural determinants and driving forces of development are analysed against the background of the innovation systems literature. Findings – The geography of innovation in China's biopharmaceutical industry is determined by both, government policy and the strategic location decisions of entrepreneurs. While local-government support of firm clustering has contributed to a dispersion of industrial activity throughout China, the firms” networks are spanning clusters. Effectively, domestic firms are turning into multi-regional companies locating activities such as R&D and manufacturing at different clusters. Originality/value – The paper adds to the literature in so far as it throws light on an until now under-researched field of China's innovation system. It identifies the concept of multi-regionalism among domestic non-state enterprises as an important parameter for understanding success and regional distribution of the industry.
- 1 April 2008
- Published by Duncker & Humblot GmbH in Vierteljahrshefte zur Wirtschaftsforschung
- Vol. 77 (2) , 162-183
Innovation im Staatsauftrag: FuE-Institute Indiens und Chinas im Vergleich
The development of innovative enterprises in China and India has been hampered for a long time due to missing linkages between the research and enterprise sector and the predominant role of public research institutes. In order to increase the international competitiveness of enterprises, both countries changed their innovation policy and created incentives for a closer cooperation among actors in the national innovation system (NIS) and supported the set up of new intermediaries. This contribution analyses the adjustment of the two largest national research institutes (CAS and CSIR) to the changes in the economic environment and their contribution to the reorientation of the NIS. Staatliche Forschungsinstitute waren in China und Indien lange Zeit die wichtigsten Träger von FuE. Die Entwicklung innovativer Unternehmen war durch die Trennung zwischen Forschungs- und Unternehmenssektor behindert. Um die internationale Wettbewerbsfähigkeit der Unternehmen zu erhöhen, erfolgte eine Neuausrichtung der Innovationspolitik in beiden Ländern. Die Anreize zur Zusammenarbeit zwischen den Akteuren im Innovationssystem stiegen. Untersucht wird, wie sich die zwei größten staatlichen Forschungsinstitute (CAS und CSIR) an die Veränderungen der ökonomischen Rahmenbedingungen angepasst und welchen Beitrag sie heute im nationalen Innovationssystem leisten.National Innovation System, Innovation Policy, Research Institutes, China, CAS, CSIR, India
- 1 April 2008
- Published by Duncker & Humblot GmbH in Vierteljahrshefte zur Wirtschaftsforschung
- Vol. 77 (2) , 162-183
Innovation im Staatsauftrag: FuE-Institute Indiens und Chinas im Vergleich
The development of innovative enterprises in China and India has been hampered for a long time due to missing linkages between the research and enterprise sector and the predominant role of public research institutes. In order to increase the international competitiveness of enterprises, both countries changed their innovation policy and created incentives for a closer cooperation among actors in the national innovation system (NIS) and supported the set up of new intermediaries. This contribution analyses the adjustment of the two largest national research institutes (CAS and CSIR) to the changes in the economic environment and their contribution to the reorientation of the NIS. Staatliche Forschungsinstitute waren in China und Indien lange Zeit die wichtigsten Träger von FuE. Die Entwicklung innovativer Unternehmen war durch die Trennung zwischen Forschungs- und Unternehmenssektor behindert. Um die internationale Wettbewerbsfähigkeit der Unternehmen zu erhöhen, erfolgte eine Neuausrichtung der Innovationspolitik in beiden Ländern. Die Anreize zur Zusammenarbeit zwischen den Akteuren im Innovationssystem stiegen. Untersucht wird, wie sich die zwei größten staatlichen Forschungsinstitute (CAS und CSIR) an die Veränderungen der ökonomischen Rahmenbedingungen angepasst und welchen Beitrag sie heute im nationalen Innovationssystem leisten.National Innovation System, Innovation Policy, Research Institutes, China, CAS, CSIR, India